162 related articles for article (PubMed ID: 37884902)
1. CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway.
Li Y; Zhang Y; Shi H; Liu X; Li Z; Zhang J; Wang X; Wang W; Tong X
Mol Med; 2023 Oct; 29(1):146. PubMed ID: 37884902
[TBL] [Abstract][Full Text] [Related]
2. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
3. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
4. [1, 25-(OH)
Huang C; Dong R; Li Z; Yuan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):325-331. PubMed ID: 37087550
[TBL] [Abstract][Full Text] [Related]
5. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
6. Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease.
Zhang X; Guan T; Yang B; Gu HF; Chi Z
Cell Death Dis; 2020 Jul; 11(7):544. PubMed ID: 32681069
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of DMDD, isolated from the root of Averrhoa carambola L., on high glucose induced EMT in HK-2 cells by inhibiting the TLR4-BAMBI-Smad2/3 signaling pathway.
Zhang H; Wei X; Lu S; Lin X; Huang J; Chen L; Huang X; Jiang L; Li Y; Qin L; Wei J; Huang R
Biomed Pharmacother; 2019 May; 113():108705. PubMed ID: 30877882
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
[TBL] [Abstract][Full Text] [Related]
9. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice.
Pang XX; Bai Q; Wu F; Chen GJ; Zhang AH; Tang CS
Kidney Blood Press Res; 2016; 41(4):434-49. PubMed ID: 27467277
[TBL] [Abstract][Full Text] [Related]
11. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
Lee GH; Cheon J; Kim D; Jun HS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
Hu Y; Tang W; Liu W; Hu Z; Pan C
Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
16. BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease.
Peng W; Zhou X; Xu T; Mao Y; Zhang X; Liu H; Liang L; Liu L; Liu L; Xiao Y; Zhang F; Li S; Shi M; Zhou Y; Tang L; Wang Y; Guo B
Cell Death Dis; 2022 Mar; 13(3):254. PubMed ID: 35314669
[TBL] [Abstract][Full Text] [Related]
17. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
[TBL] [Abstract][Full Text] [Related]
18. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
[TBL] [Abstract][Full Text] [Related]
19. Glis2 inhibits the epithelial-mesenchymal transition and apoptosis of renal tubule cells by regulating the β-catenin signalling pathway in diabetic kidney disease.
He L; Li Q; Du C; Xue Y; Yu P
Biochem Biophys Res Commun; 2022 Jun; 607():73-80. PubMed ID: 35367831
[TBL] [Abstract][Full Text] [Related]
20. Effect of Danggui-Shaoyao-San-Containing Serum on the Renal Tubular Epithelial-Mesenchymal Transition of Diabetic Nephropathy.
Xiaobing L; Chunling N; Wenyu C; Yan C; Zhenzhen L
Curr Pharm Biotechnol; 2020; 21(12):1204-1212. PubMed ID: 32297575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
